Author: healthylife7

Number of Americans Taking Weight Loss Drugs Explodes to Record High Skip to Main ContentU.S. News

Fran Drescher’s philosophy on aging is all about taking care of her body. The star of the ’90s sitcom “The Nanny” has taken a candid approach to getting older, centered less on Botox and more on feeling comfortable in her skin and taking care of herself. “You need to support your body if you want…

The viral trend that encourages women to “be a b**** or else you will develop an autoimmune disease” may have scientific backing, as studies have shown a link between suppressing emotions and the breakdown of the immune system

Our city is full of exciting people, places and businesses! H-Town Spotlight is a fun and informative segment that showcases all that Houston has to offer!

The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily reflect those of this site or affiliated companies

Your morning cup of coffee may be doing more than boosting your energy. New research suggests it might also help lower your risk of liver disease and liver cancer

Saber Healthcare Group is expanding its footprint with the acquisition of 27 skilled nursing facilities from Ciena Healthcare across Ohio, Virginia, and North Carolina, the company announced Monday

A recent Gallup poll reveals a significant increase in the use of GLP-1 medications for weight loss among Americans. As of 2026, 11% of Americans are using these drugs, a notable rise from just 3% in 2024. This surge in usage is linked to a gradual decline in the U.S. adult obesity rate, which has…

Netflix Inc. (NASDAQ: NFLX) is partnering with several leading digital publishers to bring short-form lifestyle and entertainment programming to its streaming platform, expanding the range of content available to subscribers beyond traditional films and television series

WASHINGTON, July 7, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to VCA-894A, Vanda’s investigational antisense oligonucleotide therapy for the treatment of Charcot-Marie-Tooth disease, axonal, type 2S (CMT2S), a rare, serious, and progressive inherited neurological disorder. The designation…